IBJNews

Lilly to close drug discovery center in Singapore

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. will close its drug discovery center in Singapore, three years into a five-year, $150 million plan to expand it.

About 130 employees will be affected by the closure, which will take effect as of the end of December, a Singapore-based external spokeswoman who declined to be identified said in an e-mail Monday. Projects developed in the city-state will be transferred to the company’s headquarters in Indianapolis, she said. Dow Jones Newswires reported the news earlier.

Lilly is on track to cut costs by about $1 billion by 2011, Chief Executive Officer John Lechleiter said in September. The company said last year it was reorganizing its research operations to address an “increasingly complex, slow and expensive” drug development process.

The closure “is part of our ongoing business reviews to ensure we are structured to most efficiently bring innovative new medicines to patients,” the spokeswoman said.

Lilly said in 2007 it planned to spend $150 million over five years to expand the center, with a focus on translating basic research into treatments for cancer and type 2 diabetes. The company said it planned to identify two potential drug candidates at the center within five years. The center’s employees will be able to apply for “limited jobs” at Lilly’s headquarters or to take a severance package, the company said.

The announcement comes nine days after Singapore’s government said it wanted to strengthen ties between government-funded scientists and institutes as it seeks to hasten returns on its investment in research and development. Singapore has spent almost S$20 billion ($15 million) over the past decade to become a scientific research hub and plans to spend S$16.1 billion over the next five years, it said.

“We regret Lilly’s decision,” Beh Kian Teik, director of biomedical sciences at Singapore’s Economic Development Board, said in an e-mailed statement.

Novartis AG, GlaxoSmithKline Plc and Roche Holding AG have also set up research labs in the city state. Lilly will continue to operate a clinical trial unit at the National University of Singapore, it said.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. With Pence running the ship good luck with a new government building on the site. He does everything on the cheap except unnecessary roads line a new beltway( like we need that). Things like state of the art office buildings and light rail will never be seen as an asset to these types. They don't get that these are the things that help a city prosper.

  2. Does the $100,000,000,000 include salaries for members of Congress?

  3. "But that doesn't change how the piece plays to most of the people who will see it." If it stands out so little during the day as you seem to suggest maybe most of the people who actually see it will be those present when it is dark enough to experience its full effects.

  4. That's the mentality of most retail marketers. In this case Leo was asked to build the brand. HHG then had a bad sales quarter and rather than stay the course, now want to go back to the schlock that Zimmerman provides (at a considerable cut in price.) And while HHG salesmen are, by far, the pushiest salesmen I have ever experienced, I believe they are NOT paid on commission. But that doesn't mean they aren't trained to be aggressive.

  5. The reason HHG's sales team hits you from the moment you walk through the door is the same reason car salesmen do the same thing: Commission. HHG's folks are paid by commission they and need to hit sales targets or get cut, while BB does not. The sales figures are aggressive, so turnover rate is high. Electronics are the largest commission earners along with non-needed warranties, service plans etc, known in the industry as 'cheese'. The wholesale base price is listed on the cryptic price tag in the string of numbers near the bar code. Know how to decipher it and you get things at cost, with little to no commission to the sales persons. Whether or not this is fair, is more of a moral question than a financial one.

ADVERTISEMENT